Nomura has spun off a life science venture in the latest sign that the big banks are looking to hive off their private equity activities. US fund of funds HarbourVest Partners was also an investor in the business.
The Japanese bank has sold 100% of the life science buyout business, Phase4 Ventures, to the firm's management.